GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Zimmer Biomet Holdings Inc (STU:ZIM) » Definitions » EPS (Diluted)

Zimmer Biomet Holdings (STU:ZIM) EPS (Diluted)

: €4.52 (TTM As of Dec. 2023)
View and export this data going back to . Start your Free Trial

Zimmer Biomet Holdings's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was €1.84. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was €4.52.

Zimmer Biomet Holdings's EPS (Basic) for the three months ended in Dec. 2023 was €1.85. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was €4.54.

Zimmer Biomet Holdings's EPS without NRI for the three months ended in Dec. 2023 was €2.02. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was €5.72.

During the past 12 months, Zimmer Biomet Holdings's average EPS without NRIGrowth Rate was 145.10% per year. During the past 3 years, the average EPS without NRIGrowth Rate was 10.00% per year. During the past 5 years, the average EPS without NRI Growth Rate was -7.20% per year. During the past 10 years, the average EPS without NRI Growth Rate was -2.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EPS without NRI Growth Rate using EPS without NRI data.

During the past 13 years, Zimmer Biomet Holdings's highest 3-Year average EPS without NRI Growth Rate was 46.70% per year. The lowest was -26.90% per year. And the median was 8.60% per year.


Zimmer Biomet Holdings EPS (Diluted) Historical Data

The historical data trend for Zimmer Biomet Holdings's EPS (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zimmer Biomet Holdings Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EPS (Diluted)
Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 4.92 -0.55 1.69 1.04 4.48

Zimmer Biomet Holdings Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EPS (Diluted) Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.59 1.04 0.92 0.72 1.84

Competitive Comparison

For the Medical Devices subindustry, Zimmer Biomet Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Zimmer Biomet Holdings PE Ratio Distribution

For the Medical Devices & Instruments industry and Healthcare sector, Zimmer Biomet Holdings's PE Ratio distribution charts can be found below:

* The bar in red indicates where Zimmer Biomet Holdings's PE Ratio falls into.



Zimmer Biomet Holdings EPS (Diluted) Calculation

EPS (Diluted) is a rough measurement of the amount of a company's profit that can be allocated to one share of its stock. Diluted EPS takes into account all of the outstanding dilutive securities that could potentially be exercised (such as stock options and convertible preferred stock) and shows how such an action would impact earnings per share.

Zimmer Biomet Holdings's Diluted EPS for the fiscal year that ended in Dec. 2023 is calculated as

Diluted EPS (A: Dec. 2023 ) = (Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(939.008-0)/209.700
=4.48

Zimmer Biomet Holdings's Diluted EPS for the quarter that ended in Dec. 2023 is calculated as

Diluted EPS (Q: Dec. 2023 )=(Net Income - Preferred Dividends) / Shares Outstanding (Diluted Average)
=(384.406-0)/208.500
=1.84

EPS (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €4.52

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Zimmer Biomet Holdings  (STU:ZIM) EPS (Diluted) Explanation

EPS is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.


Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.


Zimmer Biomet Holdings EPS (Diluted) Related Terms

Thank you for viewing the detailed overview of Zimmer Biomet Holdings's EPS (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.


Zimmer Biomet Holdings (STU:ZIM) Business Description

Traded in Other Exchanges
Address
345 East Main Street, Warsaw, IN, USA, 46580
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly two thirds of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, sports medicine, and related surgical products. The firm spun out its dental and spine businesses in 2022.